Bio-Rad Labs Inc. A buy Wells Fargo & Company
Start price
16.06.23
/
50%
€355.00
Target price
16.06.24
€502.10
Performance (%)
-25.32%
End price
17.06.24
€265.10
Summary
This prediction ended on 17.06.24 with a price of €265.10. The prediction for Bio-Rad Labs Inc. A disappointed with a performance of -25.32%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Bio-Rad Labs Inc. A | -2.555% | -2.555% | -11.088% |
iShares Core DAX® | -3.429% | 3.133% | 15.455% |
iShares Nasdaq 100 | -6.121% | -1.433% | 16.794% |
iShares Nikkei 225® | -7.364% | 1.018% | 8.293% |
iShares S&P 500 | -4.366% | 0.247% | 18.541% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $550.00 price target on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wells_Fargo___Compan for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€364.80
07.08.23
07.08.23
€477.33
07.08.24
07.08.24
-20.83%
08.08.24
08.08.24